Stock Rich List
#9779 on the rich list of 14,644 insiders

Richard A. Heyman

Director at Enliven Therapeutics; Director at ORIC Pharmaceuticals. Based in South San Francisco, California.

$8.7M
in disclosed stock, +$234K (+2.79%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
9779th of 14,644
Companies held
2
Largest holding
ELVN, 78.5% of total
Latest SEC filing
Oct 1, 2026
Listed but not counted
$1.2M

What the $8.7M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Enliven Therapeutics ELVN
Common Stock
Directly123,673$46.41$5.7M66.3%Form 4, Feb 17, 2026
ORIC Pharmaceuticals ORIC
Common Stock
Through RAHD Capital, LLC203,472$7.70$1.6M18.1%Form 4, Oct 1, 2026
Enliven Therapeutics ELVN
Common Stock
Through Heyman Daigle Trust22,647$46.41$1.1M12.1%Form 4, Feb 17, 2026
ORIC Pharmaceuticals ORIC
Common Stock
Directly38,300$7.70$295K3.4%Form 4, Oct 1, 2026

Share counts are the amounts Richard A. Heyman reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Richard A. Heyman's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Enliven Therapeutics ELVN
Common Stock
Through RAHD Capital LLC
Held by a company or fund the insider manages
25,545$46.41$1.2M—Form 4, Feb 17, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Oct 1, 2026SoldORIC3,500$12.91$45KView
Oct 1, 2026SoldORIC3,200$12.91$41KView
Jul 24, 2026SoldORIC7,000$12.02$84KView
Jul 24, 2026SoldORIC6,100$12.02$73KView
Jul 6, 2026SoldORIC300$12.00$4KView
Feb 17, 2026SoldELVN1,230$26.18$32KView
Jan 20, 2026SoldELVN512$26.46$14KView
Jan 20, 2026SoldELVN718$26.96$19KView
Jan 16, 2026SoldORIC3,200$12.00$38KView
Jan 16, 2026SoldORIC3,500$12.00$42KView
Jan 9, 2026SoldELVN4,285$25.00$107KView
Jan 8, 2026SoldELVN8,015$25.04$201KView
Jan 8, 2026SoldELVN1,620$25.00$41KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
9776Cynthia T Jamison
Director, Tractor Supply. Raleigh, NC
$8.7M−$113K (−1.29%)
9777Caton Frates
Sr. Executive Vice President, Costco Wholesale. Issaquah, WA
$8.7M−$22K (−0.25%)
9778Jeffry M. Householder
President & CEO, Chesapeake Utilities. Dover, DE
$8.7M−$160K (−1.82%)
9779Richard A. Heyman
Director, Enliven Therapeutics. South San Francisco, CA
$8.7M+$234K (+2.79%)
9780Shikhar Ghosh
Director, WEX. Portland, ME
$8.7M−$371K (−4.11%)
9781Robert Lonergan
EVP, CSTO, Assurant. Atlanta, GA
$8.7M−$80K (−0.92%)
9782Richard Pulik
CFO, Roivant Sciences
$8.7M+$51K (+0.59%)

Other Enliven Therapeutics insiders

All ELVN insiders

Questions

How much stock does Richard A. Heyman own?

Richard A. Heyman holds $8,652,356 in listed stock based on SEC filings and current prices, mostly Enliven Therapeutics (ELVN). That ranks 9779th on the Stock Rich List.

Is this Richard A. Heyman's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Richard A. Heyman last buy or sell stock?

The most recent open-market trade on file is a sale of 3,500 ORIC shares on Oct 1, 2026 at $12.91.